APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tiopronin Powder Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tiopronin Powder Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025197 pages

Choose your research edition.

Industry ResearchTiopronin Powder Injection Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Tiopronin Powder Injection Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Tiopronin Powder Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tiopronin Powder Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Tiopronin Powder Injection Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Tiopronin Powder Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tiopronin Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tiopronin Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tiopronin Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tiopronin Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tiopronin Powder Injection include AdvaCare Pharma, Cycle Pharma, Mission Pharmacal, Hainan Quanxing Pharmaceuticals, Hangzhou Zhongmei Huadong Pharmaceutical, Ma'anshan Fengyuan Pharmaceutical, Shandong Sino Pharmaceutical Technology, Shanxi Zhendong Taisheng Pharmaceutical and Shenyang Xinma Pharmaceutica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tiopronin Powder Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tiopronin Powder Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tiopronin Powder Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tiopronin Powder Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Tiopronin Powder Injection Segment by Company

AdvaCare Pharma

Cycle Pharma

Mission Pharmacal

Hainan Quanxing Pharmaceuticals

Hangzhou Zhongmei Huadong Pharmaceutical

Ma'anshan Fengyuan Pharmaceutical

Shandong Sino Pharmaceutical Technology

Shanxi Zhendong Taisheng Pharmaceutical

Shenyang Xinma Pharmaceutica

Wuhan Hiteck Biological Pharma

Yuanda Pharmaceutical

Yuekang Pharmaceutical

Tiopronin Powder Injection Segment by Type

0.1g per Bottle

0.2g per Bottle

Tiopronin Powder Injection Segment by Application

Fatty Liver

Drug-induced Liver Injury

Alcoholic Fatty Liver

Hepatitis

Other

Tiopronin Powder Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tiopronin Powder Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tiopronin Powder Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tiopronin Powder Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tiopronin Powder Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tiopronin Powder Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tiopronin Powder Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tiopronin Powder Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tiopronin Powder Injection Industry Trends Table 2. Tiopronin Powder Injection Industry Drivers Table 3. Tiopronin Powder Injection Industry Opportunities and Challenges Table 4. Tiopronin Powder Injection Industry Restraints Table 5. Global Tiopronin Powder Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tiopronin Powder Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tiopronin Powder Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Tiopronin Powder Injection Sales Market Share by Manufacturers Table 9. Global Tiopronin Powder Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Tiopronin Powder Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tiopronin Powder Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tiopronin Powder Injection Manufacturers, Product Type & Application Table 13. Global Tiopronin Powder Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tiopronin Powder Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.1g per Bottle Table 17. Major Manufacturers of 0.2g per Bottle Table 18. Global Tiopronin Powder Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Tiopronin Powder Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Tiopronin Powder Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Tiopronin Powder Injection Sales Market Share by Type (2021-2026) Table 22. Global Tiopronin Powder Injection Sales Market Share by Type (2027-2032) Table 23. Global Tiopronin Powder Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Tiopronin Powder Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Tiopronin Powder Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Tiopronin Powder Injection Revenue Market Share by Type (2021-2026) Table 27. Global Tiopronin Powder Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Fatty Liver Table 29. Major Manufacturers of Drug-induced Liver Injury Table 30. Major Manufacturers of Alcoholic Fatty Liver Table 31. Major Manufacturers of Hepatitis Table 32. Major Manufacturers of Other Table 33. Global Tiopronin Powder Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Tiopronin Powder Injection Sales by Application (2021-2026) & (K Units) Table 35. Global Tiopronin Powder Injection Sales by Application (2027-2032) & (K Units) Table 36. Global Tiopronin Powder Injection Sales Market Share by Application (2021-2026) Table 37. Global Tiopronin Powder Injection Sales Market Share by Application (2027-2032) Table 38. Global Tiopronin Powder Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Tiopronin Powder Injection Revenue by Application (2021-2026) & (K Units) Table 40. Global Tiopronin Powder Injection Revenue by Application (2027-2032) & (K Units) Table 41. Global Tiopronin Powder Injection Revenue Market Share by Application (2021-2026) Table 42. Global Tiopronin Powder Injection Revenue Market Share by Application (2027-2032) Table 43. Global Tiopronin Powder Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Tiopronin Powder Injection Sales by Region (2021-2026) & (K Units) Table 45. Global Tiopronin Powder Injection Sales Market Share by Region (2021-2026) Table 46. Global Tiopronin Powder Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Tiopronin Powder Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Tiopronin Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Tiopronin Powder Injection Sales by Country (2021-2026) & (K Units) Table 50. North America Tiopronin Powder Injection Sales by Country (2027-2032) & (K Units) Table 51. Europe Tiopronin Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Tiopronin Powder Injection Sales by Country (2021-2026) & (K Units) Table 53. Europe Tiopronin Powder Injection Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Tiopronin Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Tiopronin Powder Injection Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Tiopronin Powder Injection Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Tiopronin Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Tiopronin Powder Injection Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Tiopronin Powder Injection Sales by Country (2027-2032) & (K Units) Table 60. Global Tiopronin Powder Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Tiopronin Powder Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Tiopronin Powder Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Tiopronin Powder Injection Revenue Market Share by Region (2021-2026) Table 64. Global Tiopronin Powder Injection Revenue Market Share by Region (2027-2032) Table 65. AdvaCare Pharma Company Information Table 66. AdvaCare Pharma Business Overview Table 67. AdvaCare Pharma Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. AdvaCare Pharma Tiopronin Powder Injection Product Portfolio Table 69. AdvaCare Pharma Recent Development Table 70. Cycle Pharma Company Information Table 71. Cycle Pharma Business Overview Table 72. Cycle Pharma Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Cycle Pharma Tiopronin Powder Injection Product Portfolio Table 74. Cycle Pharma Recent Development Table 75. Mission Pharmacal Company Information Table 76. Mission Pharmacal Business Overview Table 77. Mission Pharmacal Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Mission Pharmacal Tiopronin Powder Injection Product Portfolio Table 79. Mission Pharmacal Recent Development Table 80. Hainan Quanxing Pharmaceuticals Company Information Table 81. Hainan Quanxing Pharmaceuticals Business Overview Table 82. Hainan Quanxing Pharmaceuticals Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Hainan Quanxing Pharmaceuticals Tiopronin Powder Injection Product Portfolio Table 84. Hainan Quanxing Pharmaceuticals Recent Development Table 85. Hangzhou Zhongmei Huadong Pharmaceutical Company Information Table 86. Hangzhou Zhongmei Huadong Pharmaceutical Business Overview Table 87. Hangzhou Zhongmei Huadong Pharmaceutical Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Hangzhou Zhongmei Huadong Pharmaceutical Tiopronin Powder Injection Product Portfolio Table 89. Hangzhou Zhongmei Huadong Pharmaceutical Recent Development Table 90. Ma'anshan Fengyuan Pharmaceutical Company Information Table 91. Ma'anshan Fengyuan Pharmaceutical Business Overview Table 92. Ma'anshan Fengyuan Pharmaceutical Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Ma'anshan Fengyuan Pharmaceutical Tiopronin Powder Injection Product Portfolio Table 94. Ma'anshan Fengyuan Pharmaceutical Recent Development Table 95. Shandong Sino Pharmaceutical Technology Company Information Table 96. Shandong Sino Pharmaceutical Technology Business Overview Table 97. Shandong Sino Pharmaceutical Technology Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Shandong Sino Pharmaceutical Technology Tiopronin Powder Injection Product Portfolio Table 99. Shandong Sino Pharmaceutical Technology Recent Development Table 100. Shanxi Zhendong Taisheng Pharmaceutical Company Information Table 101. Shanxi Zhendong Taisheng Pharmaceutical Business Overview Table 102. Shanxi Zhendong Taisheng Pharmaceutical Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Shanxi Zhendong Taisheng Pharmaceutical Tiopronin Powder Injection Product Portfolio Table 104. Shanxi Zhendong Taisheng Pharmaceutical Recent Development Table 105. Shenyang Xinma Pharmaceutica Company Information Table 106. Shenyang Xinma Pharmaceutica Business Overview Table 107. Shenyang Xinma Pharmaceutica Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Shenyang Xinma Pharmaceutica Tiopronin Powder Injection Product Portfolio Table 109. Shenyang Xinma Pharmaceutica Recent Development Table 110. Wuhan Hiteck Biological Pharma Company Information Table 111. Wuhan Hiteck Biological Pharma Business Overview Table 112. Wuhan Hiteck Biological Pharma Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Wuhan Hiteck Biological Pharma Tiopronin Powder Injection Product Portfolio Table 114. Wuhan Hiteck Biological Pharma Recent Development Table 115. Yuanda Pharmaceutical Company Information Table 116. Yuanda Pharmaceutical Business Overview Table 117. Yuanda Pharmaceutical Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Yuanda Pharmaceutical Tiopronin Powder Injection Product Portfolio Table 119. Yuanda Pharmaceutical Recent Development Table 120. Yuekang Pharmaceutical Company Information Table 121. Yuekang Pharmaceutical Business Overview Table 122. Yuekang Pharmaceutical Tiopronin Powder Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Yuekang Pharmaceutical Tiopronin Powder Injection Product Portfolio Table 124. Yuekang Pharmaceutical Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Tiopronin Powder Injection Distributors List Table 128. Tiopronin Powder Injection Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Tiopronin Powder Injection Product Image Figure 2. Global Tiopronin Powder Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tiopronin Powder Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Tiopronin Powder Injection Sales (2021-2032) & (K Units) Figure 5. Global Tiopronin Powder Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tiopronin Powder Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.1g per Bottle Image Figure 9. 0.2g per Bottle Image Figure 10. Global Tiopronin Powder Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Tiopronin Powder Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tiopronin Powder Injection Sales Market Share by Type (2021-2032) Figure 13. Global Tiopronin Powder Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Tiopronin Powder Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tiopronin Powder Injection Revenue Market Share by Type (2021-2032) Figure 16. Fatty Liver Image Figure 17. Drug-induced Liver Injury Image Figure 18. Alcoholic Fatty Liver Image Figure 19. Hepatitis Image Figure 20. Other Image Figure 21. Global Tiopronin Powder Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Tiopronin Powder Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Tiopronin Powder Injection Sales Market Share by Application (2021-2032) Figure 24. Global Tiopronin Powder Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Tiopronin Powder Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Tiopronin Powder Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Tiopronin Powder Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Tiopronin Powder Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Tiopronin Powder Injection Sales Market Share by Country (2021-2032) Figure 41. China Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Tiopronin Powder Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Tiopronin Powder Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Tiopronin Powder Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Tiopronin Powder Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Tiopronin Powder Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Tiopronin Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Tiopronin Powder Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Tiopronin Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Tiopronin Powder Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Tiopronin Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Tiopronin Powder Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Tiopronin Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Tiopronin Powder Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Tiopronin Powder Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.1g per Bottle
  • 0.2g per Bottle
Applications
  • Fatty Liver
  • Drug-induced Liver Injury
  • Alcoholic Fatty Liver
  • Hepatitis
  • Other
Companies covered
  • AdvaCare Pharma
  • Cycle Pharma
  • Mission Pharmacal
  • Hainan Quanxing Pharmaceuticals
  • Hangzhou Zhongmei Huadong Pharmaceutical
  • Ma'anshan Fengyuan Pharmaceutical
  • Shandong Sino Pharmaceutical Technology
  • Shanxi Zhendong Taisheng Pharmaceutical
  • Shenyang Xinma Pharmaceutica
  • Wuhan Hiteck Biological Pharma
  • Yuanda Pharmaceutical
  • Yuekang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tiopronin Powder Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tiopronin Powder Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tiopronin Powder Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tiopronin Powder Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tiopronin Powder Injection Market Dynamics
  1. 2.1 Tiopronin Powder Injection Industry Trends
  2. 2.2 Tiopronin Powder Injection Industry Drivers
  3. 2.3 Tiopronin Powder Injection Industry Opportunities and Challenges
  4. 2.4 Tiopronin Powder Injection Industry Restraints
3 Tiopronin Powder Injection Market by Manufacturers
  1. 3.1 Global Tiopronin Powder Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tiopronin Powder Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tiopronin Powder Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tiopronin Powder Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tiopronin Powder Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tiopronin Powder Injection Manufacturers, Product Type & Application
  7. 3.7 Global Tiopronin Powder Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tiopronin Powder Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tiopronin Powder Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tiopronin Powder Injection Tier 1, Tier 2, and Tier 3
4 Tiopronin Powder Injection Market by Type
  1. 4.1 Tiopronin Powder Injection Type Introduction
  2. 4.1.1 0.1g per Bottle
  3. 4.1.2 0.2g per Bottle
  4. 4.2 Global Tiopronin Powder Injection Sales by Type
  5. 4.2.1 Global Tiopronin Powder Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tiopronin Powder Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Tiopronin Powder Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tiopronin Powder Injection Revenue by Type
  9. 4.3.1 Global Tiopronin Powder Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tiopronin Powder Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Tiopronin Powder Injection Revenue Market Share by Type (2021-2032)
5 Tiopronin Powder Injection Market by Application
  1. 5.1 Tiopronin Powder Injection Application Introduction
  2. 5.1.1 Fatty Liver
  3. 5.1.2 Drug-induced Liver Injury
  4. 5.1.3 Alcoholic Fatty Liver
  5. 5.1.4 Hepatitis
  6. 5.1.5 Other
  7. 5.2 Global Tiopronin Powder Injection Sales by Application
  8. 5.2.1 Global Tiopronin Powder Injection Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Tiopronin Powder Injection Sales by Application (2021-2032)
  10. 5.2.3 Global Tiopronin Powder Injection Sales Market Share by Application (2021-2032)
  11. 5.3 Global Tiopronin Powder Injection Revenue by Application
  12. 5.3.1 Global Tiopronin Powder Injection Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Tiopronin Powder Injection Revenue by Application (2021-2032)
  14. 5.3.3 Global Tiopronin Powder Injection Revenue Market Share by Application (2021-2032)
6 Global Tiopronin Powder Injection Sales by Region
  1. 6.1 Global Tiopronin Powder Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tiopronin Powder Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Tiopronin Powder Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Tiopronin Powder Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tiopronin Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tiopronin Powder Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tiopronin Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tiopronin Powder Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tiopronin Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tiopronin Powder Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tiopronin Powder Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tiopronin Powder Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tiopronin Powder Injection Revenue by Region
  1. 7.1 Global Tiopronin Powder Injection Revenue by Region
  2. 7.1.1 Global Tiopronin Powder Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tiopronin Powder Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Tiopronin Powder Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Tiopronin Powder Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tiopronin Powder Injection Revenue (2021-2032)
  8. 7.2.2 North America Tiopronin Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tiopronin Powder Injection Revenue (2021-2032)
  11. 7.3.2 Europe Tiopronin Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tiopronin Powder Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tiopronin Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tiopronin Powder Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tiopronin Powder Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AdvaCare Pharma
  2. 8.1.1 AdvaCare Pharma Company Information
  3. 8.1.2 AdvaCare Pharma Business Overview
  4. 8.1.3 AdvaCare Pharma Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AdvaCare Pharma Tiopronin Powder Injection Product Portfolio
  6. 8.1.5 AdvaCare Pharma Recent Developments
  7. 8.2 Cycle Pharma
  8. 8.2.1 Cycle Pharma Company Information
  9. 8.2.2 Cycle Pharma Business Overview
  10. 8.2.3 Cycle Pharma Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cycle Pharma Tiopronin Powder Injection Product Portfolio
  12. 8.2.5 Cycle Pharma Recent Developments
  13. 8.3 Mission Pharmacal
  14. 8.3.1 Mission Pharmacal Company Information
  15. 8.3.2 Mission Pharmacal Business Overview
  16. 8.3.3 Mission Pharmacal Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mission Pharmacal Tiopronin Powder Injection Product Portfolio
  18. 8.3.5 Mission Pharmacal Recent Developments
  19. 8.4 Hainan Quanxing Pharmaceuticals
  20. 8.4.1 Hainan Quanxing Pharmaceuticals Company Information
  21. 8.4.2 Hainan Quanxing Pharmaceuticals Business Overview
  22. 8.4.3 Hainan Quanxing Pharmaceuticals Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hainan Quanxing Pharmaceuticals Tiopronin Powder Injection Product Portfolio
  24. 8.4.5 Hainan Quanxing Pharmaceuticals Recent Developments
  25. 8.5 Hangzhou Zhongmei Huadong Pharmaceutical
  26. 8.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
  27. 8.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
  28. 8.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Tiopronin Powder Injection Product Portfolio
  30. 8.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
  31. 8.6 Ma'anshan Fengyuan Pharmaceutical
  32. 8.6.1 Ma'anshan Fengyuan Pharmaceutical Company Information
  33. 8.6.2 Ma'anshan Fengyuan Pharmaceutical Business Overview
  34. 8.6.3 Ma'anshan Fengyuan Pharmaceutical Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ma'anshan Fengyuan Pharmaceutical Tiopronin Powder Injection Product Portfolio
  36. 8.6.5 Ma'anshan Fengyuan Pharmaceutical Recent Developments
  37. 8.7 Shandong Sino Pharmaceutical Technology
  38. 8.7.1 Shandong Sino Pharmaceutical Technology Company Information
  39. 8.7.2 Shandong Sino Pharmaceutical Technology Business Overview
  40. 8.7.3 Shandong Sino Pharmaceutical Technology Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Sino Pharmaceutical Technology Tiopronin Powder Injection Product Portfolio
  42. 8.7.5 Shandong Sino Pharmaceutical Technology Recent Developments
  43. 8.8 Shanxi Zhendong Taisheng Pharmaceutical
  44. 8.8.1 Shanxi Zhendong Taisheng Pharmaceutical Company Information
  45. 8.8.2 Shanxi Zhendong Taisheng Pharmaceutical Business Overview
  46. 8.8.3 Shanxi Zhendong Taisheng Pharmaceutical Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanxi Zhendong Taisheng Pharmaceutical Tiopronin Powder Injection Product Portfolio
  48. 8.8.5 Shanxi Zhendong Taisheng Pharmaceutical Recent Developments
  49. 8.9 Shenyang Xinma Pharmaceutica
  50. 8.9.1 Shenyang Xinma Pharmaceutica Company Information
  51. 8.9.2 Shenyang Xinma Pharmaceutica Business Overview
  52. 8.9.3 Shenyang Xinma Pharmaceutica Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shenyang Xinma Pharmaceutica Tiopronin Powder Injection Product Portfolio
  54. 8.9.5 Shenyang Xinma Pharmaceutica Recent Developments
  55. 8.10 Wuhan Hiteck Biological Pharma
  56. 8.10.1 Wuhan Hiteck Biological Pharma Company Information
  57. 8.10.2 Wuhan Hiteck Biological Pharma Business Overview
  58. 8.10.3 Wuhan Hiteck Biological Pharma Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Wuhan Hiteck Biological Pharma Tiopronin Powder Injection Product Portfolio
  60. 8.10.5 Wuhan Hiteck Biological Pharma Recent Developments
  61. 8.11 Yuanda Pharmaceutical
  62. 8.11.1 Yuanda Pharmaceutical Company Information
  63. 8.11.2 Yuanda Pharmaceutical Business Overview
  64. 8.11.3 Yuanda Pharmaceutical Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Yuanda Pharmaceutical Tiopronin Powder Injection Product Portfolio
  66. 8.11.5 Yuanda Pharmaceutical Recent Developments
  67. 8.12 Yuekang Pharmaceutical
  68. 8.12.1 Yuekang Pharmaceutical Company Information
  69. 8.12.2 Yuekang Pharmaceutical Business Overview
  70. 8.12.3 Yuekang Pharmaceutical Tiopronin Powder Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yuekang Pharmaceutical Tiopronin Powder Injection Product Portfolio
  72. 8.12.5 Yuekang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tiopronin Powder Injection Value Chain Analysis
  2. 9.1.1 Tiopronin Powder Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tiopronin Powder Injection Production Mode & Process
  6. 9.2 Tiopronin Powder Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tiopronin Powder Injection Distributors
  9. 9.2.3 Tiopronin Powder Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst